Ctrl K
MediWound faces a precarious financial outlook characterized by a 62.7% year-over-year revenue decline in 2026Q1 and a structural inability to achieve operational profitability. Th...
EPS beat 9 of last 12 quarters
P/E is 124% below its peer median
Laggard (Underperforming 74% of market)
Price < 200DMA
Estimated earnings - Aug 27
Trailing total returns as of 7/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
MediWound Ltd. (MDWD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 27, 2026 | $0.23vs $0.65+64.6% | $1Mvs $3M-56.2% |
| Q2 2026 | Mar 5, 2026 | $0.56vs $0.65+13.8% | $2Mvs $4M-55.5% |
| Q4 2025 | Nov 20, 2025 | $0.24vs $0.81+70.4% | $5Mvs $2M+160.1% |
| Q3 2025 | Aug 14, 2025 | $1.23vs $0.55-123.6% | $6Mvs $7M-13.0% |
Key metrics vs top competitors for MediWound Ltd. (MDWD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $14.45 | $156.96M | -6.88 | -16.14% | -140.8% | -63.86% | — | |
| $2.47 | $796.29K | -0.03 | — | — | -516.87% | — | |
| $17.03 | $1.97B | -13.96 | 8.28% | -21.25% | -44% | — | |
| $29.79 | $1.46B | -119.16 | 16.97% | -10.52% | -2.91% | — | |
| $10.21 | $326.7M | 4.44 | 6774.96% | -256.6% | -17.04% | — | |
| $81.48 | $9.66B | 31.83 | 37.55% | 23.13% | 126.27% | — |
MediWound Ltd. (MDWD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MDWD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MediWound Ltd. (MDWD) stock FAQ — growth, dividends, profitability & financials explained
MediWound Ltd. (MDWD) reported $14.5M in revenue for fiscal year 2025.
MediWound Ltd. (MDWD) saw revenue decline by 16.1% over the past year.
MediWound Ltd. (MDWD) reported a net loss of $26.1M for fiscal year 2025.
MediWound Ltd. (MDWD) has a return on equity (ROE) of -63.9%. Negative ROE indicates the company is unprofitable.
MediWound Ltd. (MDWD) had negative free cash flow of $24.3M in fiscal year 2025, likely due to heavy capital investments.
